Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows.
Goldman Sachs Maintains Neutral on Baxter Intl, Lowers Price Target to $80
Goldman Sachs maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $93 to $80.
Keybanc Maintains Overweight on Baxter Intl, Lowers Price Target to $92
Keybanc analyst Matthew Mishan maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $94 to $92.
Earnings Scheduled For July 29, 2021
Companies Reporting Before The Bell
• Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
Baxter Highlights Findings In a Study Published In The Journal Of Medical Economics
Authors conclude that using active hemostatic products alone was associated with improved outcomes for surgical patients compared to a combination of passive and active hemostatic products
Baxter International Inc.
Moderna’s COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested
Moderna Inc (NASDAQ:MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine.…
IPO Preview: Full Truck Alliance, Sprinklr, Mister Car Wash, Soulgate Lead Busy Week Of 10+ Offerings
The week of June 21 is setting up to be one of the busiest IPO weeks in some time with more than dozen companies that could go public with listings.
Here is a look at some of the biggest IPOs of the week with the details investors should know.
Barclays Initiates Coverage On Baxter Intl with Equal-Weight Rating, Announces Price Target of $93
Barclays analyst Travis Steed initiates coverage on Baxter Intl (NYSE:BAX) with a Equal-Weight rating and announces Price Target of $93.